HSChapter 30
U.S. imports of corticosteroid hormone medicaments in dosage form (HS 300432) totaled $165.7M in July 2026, traded with 25 countries.
Corticosteroid Hormone Medicaments in Dosage Form imports of $165.7M in July 2026 ran 11% below the year-to-date monthly average of $185.9M.
Last updated: July 2026 dataFinished-dose corticosteroid preparations — including dedicated lines for dexamethasone (3004320010) and methylprednisolone (3004320040) alongside a broader catch-all (3004320060) — reflect the clinical breadth of this drug class, which spans anti-inflammatory, immunosuppressive, and critical-care applications. France leads US supply under this heading, with India, Ireland, Canada, and the United Kingdom also significant sources. Dexamethasone's prominence as a COVID-19 treatment elevated supply-chain scrutiny for this specific molecule, and importers should be aware that manufacturing quality issues at foreign facilities have historically triggered FDA import alerts for corticosteroid injectables. All entries require FDA approval of the specific product and facility.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
419 shipments/mo
The US schedule assigns dexamethasone and methylprednisolone their own 10-digit lines because of their commercial volume and regulatory monitoring interest. A product containing dexamethasone as its active corticosteroid should be classified under 3004320010 rather than the residual line. Products containing other corticosteroids (e.g., prednisone, hydrocortisone, betamethasone) that are not specifically named fall under 3004320060. Importers should confirm the active ingredient identity on the certificate of analysis.
Yes. Injectable corticosteroid products, particularly those manufactured at facilities with prior FDA warning letters or import alerts, are subject to enhanced examination. FDA has historically placed sterile injectable manufacturers on import alert for cGMP deficiencies. Importers should review the FDA import alert database for their specific foreign manufacturer before committing to a supply arrangement.
Supplier Network
Get discovered by U.S. importers searching for HS 300432 — Corticosteroid Hormone Medicaments in Dosage Form. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Dutiable Share |
|---|---|---|---|---|
| 3004320080 | Medicaments Containing Corticosteroid Hormones Etc | $146.8M | 0.00% | 0.00% |
| 3004320020 | Containing Hydrocortisone or Its Salts | $10.4M | 0.00% | 0.00% |
| 3004320040 | Meds Cont Crticstroid Hrmns,Cont Methylprdnisolone | $6.7M | 0.00% | 0.00% |
| 3004320010 | Meds Cont Corticosteroid Hrmnes,Cont Dexamethasone | $1.8M | 0.00% | 0.00% |
| 3004320000 | Medicaments Containing Corticosteroid Hormones Etc | $0 | -- | -- |
| 3004320060 | Medicaments Containing Corticosteroid Hormones Etc | $0 | -- | -- |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3004320000 | Medicaments Containing Corticosteroid Hormones Etc | $34.5M |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
ImportsExports
Imports
$165.7MYoY · Pro
Exports
$34.5MYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.
Imports · July 2026
origin
France and United Kingdom together supply 63% of it.
customs district
destination
entry
rate provision · imports
100.0% enters free of duty; the effective duty rate is 0.00%.